Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars, Webinars Posted on May 21, 2021 FacebookTwitterLinkedinPin ItWhatsApp You may also like 29:46 Update on Investigational Suvodirsen in Duchenne Muscular Dystrophy (December 2019) Posted on January 15, 2020 Research & Clinical Trial Webinars, Webinars 1:17:48 Better Todays. Stronger Tomorrows. (December 2019) Posted on December 20, 2019 Care Webinars, Research & Clinical Trial Webinars, Webinars 35:37 NS Pharma Provides Viltolarsen Update (November 2019) Posted on November 26, 2019 Research & Clinical Trial Webinars, Webinars 47:13 DYSTANCE 51, a Phase 2/3 Clinical Trial of Investigational Suvodirsen in Duchenne (October 2019) Posted on October 23, 2019 Research & Clinical Trial Webinars, Webinars 52:44 Community Discussion with Sarepta Therapeutics (August 2019) Posted on August 22, 2019 Research & Clinical Trial Webinars, Webinars 18:32 Adaptive Sports (August 2019) Posted on August 22, 2019 For Teens & Adults, PPMD Adult Advisory Committee (PAAC) Webinars, Webinars 57:50 Capricor’s HOPE-2 Interim Analysis (July 2019) Posted on July 19, 2019 Research & Clinical Trial Webinars, Webinars 36:52 Rolling Around the World (June 2019) Posted on June 17, 2019 For Teens & Adults, PPMD Adult Advisory Committee (PAAC) Webinars, Webinars «1…1112131415…24»Page 13 of 24